Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
28712 | 201 | 43.4 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
17 | 4 | REPRODUCTIVE BIOLOGY//OBSTETRICS & GYNECOLOGY//VETERINARY SCIENCES | 563730 |
132 | 3 | REPRODUCTIVE BIOLOGY//FERTILITY AND STERILITY//OBSTETRICS & GYNECOLOGY | 66807 |
3005 | 2 | ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//LHRH RECEPTOR | 2547 |
28712 | 1 | ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//GROWTH HORMONE RELEASING HORMONE ANTAGONIST | 201 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ENDOCRINE POLYPEPTIDE CANC | address | 5057980 | 42% | 39% | 85 |
2 | GHRH ANTAGONISTS | authKW | 4474649 | 18% | 82% | 36 |
3 | GROWTH HORMONE RELEASING HORMONE ANTAGONIST | authKW | 1381067 | 5% | 91% | 10 |
4 | SECT EXPT MED | address | 893399 | 14% | 20% | 29 |
5 | GHRH RECEPTOR | authKW | 705667 | 6% | 39% | 12 |
6 | MZ 4 71 | authKW | 607670 | 2% | 100% | 4 |
7 | GHRH | authKW | 483076 | 15% | 11% | 30 |
8 | S FLORIDA VET AFFAIRS FDN EDUC | address | 474739 | 2% | 63% | 5 |
9 | SV1 | authKW | 347237 | 2% | 57% | 4 |
10 | ANTAGONISTIC ANALOGS | authKW | 303835 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 3046 | 47% | 0% | 95 |
2 | Oncology | 901 | 35% | 0% | 71 |
3 | Cell Biology | 96 | 13% | 0% | 26 |
4 | Urology & Nephrology | 79 | 6% | 0% | 13 |
5 | Pharmacology & Pharmacy | 60 | 12% | 0% | 25 |
6 | Biochemistry & Molecular Biology | 17 | 12% | 0% | 25 |
7 | Reproductive Biology | 14 | 2% | 0% | 4 |
8 | Multidisciplinary Sciences | 11 | 1% | 0% | 3 |
9 | Behavioral Sciences | 9 | 2% | 0% | 4 |
10 | Physiology | 6 | 3% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENDOCRINE POLYPEPTIDE CANC | 5057980 | 42% | 39% | 85 |
2 | SECT EXPT MED | 893399 | 14% | 20% | 29 |
3 | S FLORIDA VET AFFAIRS FDN EDUC | 474739 | 2% | 63% | 5 |
4 | SECT EXPTL MED | 303835 | 1% | 100% | 2 |
5 | SOUTH FLORIDA VET AFFAIRS FDN EDUC | 303835 | 1% | 100% | 2 |
6 | POLYPEPTIDE CANC | 273449 | 1% | 60% | 3 |
7 | ALBERT SZERT GYORGYI MED | 151918 | 0% | 100% | 1 |
8 | BLDG 10B1L400 | 151918 | 0% | 100% | 1 |
9 | CELLULAR BIOL PHYSIOL INMUNOL | 151918 | 0% | 100% | 1 |
10 | ENDOCRINOL REPROD BRANCHMOLEC ENDOCRINOL SECT | 151918 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HORMONES & CANCER | 4216 | 1% | 1% | 2 |
2 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2973 | 21% | 0% | 43 |
3 | PROSTATE | 2700 | 4% | 0% | 9 |
4 | PEPTIDES | 1101 | 4% | 0% | 8 |
5 | ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION A-PATHOLOGY | 1083 | 0% | 1% | 1 |
6 | CELL CYCLE | 921 | 1% | 0% | 2 |
7 | NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 833 | 0% | 1% | 1 |
8 | INTERNATIONAL JOURNAL OF ONCOLOGY | 773 | 3% | 0% | 7 |
9 | ENDOCRINE | 767 | 2% | 0% | 4 |
10 | RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY | 582 | 0% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GHRH ANTAGONISTS | 4474649 | 18% | 82% | 36 | Search GHRH+ANTAGONISTS | Search GHRH+ANTAGONISTS |
2 | GROWTH HORMONE RELEASING HORMONE ANTAGONIST | 1381067 | 5% | 91% | 10 | Search GROWTH+HORMONE+RELEASING+HORMONE+ANTAGONIST | Search GROWTH+HORMONE+RELEASING+HORMONE+ANTAGONIST |
3 | GHRH RECEPTOR | 705667 | 6% | 39% | 12 | Search GHRH+RECEPTOR | Search GHRH+RECEPTOR |
4 | MZ 4 71 | 607670 | 2% | 100% | 4 | Search MZ+4+71 | Search MZ+4+71 |
5 | GHRH | 483076 | 15% | 11% | 30 | Search GHRH | Search GHRH |
6 | SV1 | 347237 | 2% | 57% | 4 | Search SV1 | Search SV1 |
7 | ANTAGONISTIC ANALOGS | 303835 | 1% | 100% | 2 | Search ANTAGONISTIC+ANALOGS | Search ANTAGONISTIC+ANALOGS |
8 | GHRH R ANTAGONIST | 303835 | 1% | 100% | 2 | Search GHRH+R+ANTAGONIST | Search GHRH+R+ANTAGONIST |
9 | GROWTH HORMONE RELEASING HORMONE RELATED PEPTIDE | 303835 | 1% | 100% | 2 | Search GROWTH+HORMONE+RELEASING+HORMONE+RELATED+PEPTIDE | Search GROWTH+HORMONE+RELEASING+HORMONE+RELATED+PEPTIDE |
10 | HUMAN MALIGNANT BONE TUMORS | 303835 | 1% | 100% | 2 | Search HUMAN+MALIGNANT+BONE+TUMORS | Search HUMAN+MALIGNANT+BONE+TUMORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCHALLY, AV , VARGA, JL , (2006) ANTAGONISTS OF GROWTH HORMONE-RELEASING HORMONE IN ONCOLOGY.COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING. VOL. 9. ISSUE 3. P. 163-170 | 48 | 87% | 40 |
2 | GUO, JA , SCHALLY, AV , ZARANDI, M , VARGA, J , LEUNG, PCK , (2010) ANTIPROLIFERATIVE EFFECT OF GROWTH HORMONE-RELEASING HORMONE (GHRH) ANTAGONIST ON OVARIAN CANCER CELLS THROUGH THE EGFR-AKT PATHWAY.REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY. VOL. 8. ISSUE . P. - | 41 | 82% | 8 |
3 | KOVACS, M , SCHALLY, AV , VARGA, JL , ZARANDI, M , (2008) ENDOCRINE AND ANTINEOPLASTIC ACTIONS OF GROWTH HORMONE-RELEASING HORMONE ANTAGONISTS.CURRENT MEDICINAL CHEMISTRY. VOL. 15. ISSUE 4. P. 314 -321 | 53 | 64% | 4 |
4 | SCHALLY, AV , VARGA, JL , ENGEL, JB , (2008) ANTAGONISTS OF GROWTH-HORMONE-RELEASING HORMONE: AN EMERGING NEW THERAPY FOR CANCER.NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM. VOL. 4. ISSUE 1. P. 33-43 | 47 | 64% | 37 |
5 | SIEJKA, A , LAWNICKA, H , MELEN-MUCHA, G , MOTYLEWSKA, E , KOMOROWSKI, J , STEPIEN, H , (2012) ANTINEOPLASTIC ACTION OF GROWTH HORMONE-RELEASING HORMONE (GHRH) ANTAGONISTS.RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY. VOL. 7. ISSUE 1. P. 56-63 | 44 | 65% | 2 |
6 | ENGEL, JB , KELLER, G , SCHALLY, AV , TOLLER, GL , GROOT, K , HAVT, A , ARMATIS, P , ZARANDI, M , VARGA, JL , HALMOS, G , (2005) INHIBITION OF GROWTH OF EXPERIMENTAL HUMAN ENDOMETRIAL CANCER BY AN ANTAGONIST OF GROWTH HORMONE-RELEASING HORMONE.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 90. ISSUE 6. P. 3614 -3621 | 37 | 76% | 23 |
7 | POZSGAI, E , SCHALLY, AV , HOCSAK, E , ZARANDI, M , RICK, F , BELLYEI, S , (2011) THE EFFECT OF A NOVEL ANTAGONIST OF GROWTH HORMONE RELEASING HORMONE ON CELL PROLIFERATION AND ON THE KEY CELL SIGNALING PATHWAYS IN NINE DIFFERENT BREAST CANCER CELL LINES.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 39. ISSUE 4. P. 1025-1032 | 30 | 77% | 1 |
8 | KOSTER, F , ENGEL, JB , SCHALLY, AV , HONIG, A , SCHROER, A , SEITZ, S , HOHLA, F , ORTMANN, O , DIEDRICH, K , BUCHHOLZ, S , (2009) TRIPLE-NEGATIVE BREAST CANCERS EXPRESS RECEPTORS FOR GROWTH HORMONE-RELEASING HORMONE (GHRH) AND RESPOND TO GHRH ANTAGONISTS WITH GROWTH INHIBITION.BREAST CANCER RESEARCH AND TREATMENT. VOL. 116. ISSUE 2. P. 273 -279 | 31 | 76% | 7 |
9 | BARABUTIS, N , SCHALLY, AV , (2010) GROWTH HORMONE-RELEASING HORMONE EXTRAPITUITARY EFFECTS IN PHYSIOLOGY AND PATHOLOGY.CELL CYCLE. VOL. 9. ISSUE 20. P. 4110 -4116 | 51 | 42% | 19 |
10 | HALMOS, G , SCHALLY, AV , BERNARDINO, ALF , VARGA, JL , (2006) CHARACTERIZATION OF RECEPTORS FOR GROWTH HORMONE-RELEASING HORMONE IN HUMAN OSTEOSARCOMAS AND EWING'S SARCOMAS.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 29. ISSUE 2. P. 463-469 | 32 | 76% | 0 |
Classes with closest relation at Level 1 |